↓ Skip to main content

Role and potential for therapeutic targeting of MYB in leukemia

Overview of attention for article published in Leukemia, August 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
112 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role and potential for therapeutic targeting of MYB in leukemia
Published in
Leukemia, August 2012
DOI 10.1038/leu.2012.225
Pubmed ID
Authors

D R Pattabiraman, T J Gonda

Abstract

The Myb protein was first identified as an oncogene that causes leukemia in chickens. Since then, it has been widely associated with different types of cancers and studied in detail in myeloid leukemias. However, despite these studies, its role in the induction, pathogenesis and maintenance of AML, and other blood disorders, is still not well understood. Recent efforts to uncover its plethora of transcriptional targets have provided key insights into understanding its mechanism of action. This review evaluates our current knowledge of the role of Myb in leukemia, with a particular focus on AML, from the vast literature spanning three decades, highlighting key studies that have influenced our understanding. We discuss recent insights into its role in leukemogenesis and how these could be exploited for the therapeutic targeting of Myb, its associated co-regulators or its target genes, in order to improve outcomes in the treatment of a wide range of hematopoietic malignancies.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Italy 1 1%
Unknown 82 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 20 24%
Researcher 19 23%
Student > Master 8 10%
Student > Bachelor 6 7%
Professor 5 6%
Other 6 7%
Unknown 20 24%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 24%
Agricultural and Biological Sciences 19 23%
Medicine and Dentistry 14 17%
Chemistry 6 7%
Computer Science 1 1%
Other 2 2%
Unknown 22 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 February 2013.
All research outputs
#19,512,854
of 24,003,070 outputs
Outputs from Leukemia
#4,655
of 5,213 outputs
Outputs of similar age
#130,771
of 169,161 outputs
Outputs of similar age from Leukemia
#43
of 51 outputs
Altmetric has tracked 24,003,070 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,213 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,161 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.